Terms Unconditional

Consumer Apps · Health/Pharmacy · Regulatory action

CVS Health / CVS app

Headline

CVS Caremark (CVS's own pharmacy-benefits arm) is one of three companies the FTC accused of artificially inflating INSULIN prices through a rebate scheme documented elsewhere in this tracker…

Not independently verified. Verification status: Unverified - heuristic first draft. Publish state: draft unverified.

CVS Caremark (CVS's own pharmacy-benefits arm) is one of three companies the FTC accused of artificially inflating INSULIN prices through a rebate scheme documented elsewhere in this tracker (allegations only: Caremark settled the FTC case on July 14, 2026 with conduct remedies, no monetary penalty and no finding of liability, following Express Scripts' Feb 2026 settlement) — meaning the pharmacy chain millions rely on for prescriptions is also the entity accused of helping make one of the most essential, life-sustaining medications more expensive than it needed to be.

  • SeveritySeverity 3 of 5, not independently verified. CVS Caremark (CVS's own pharmacy-benefits arm) is one of three companies the FTC accused of artificially inflating INSULIN prices through a rebate scheme documented elsewhere in this tracker…
  • Evidence tierUnassigned
  • Claims confirmedNo sourced claims yet
  • Last verified2026-08-04

Primary source. None recorded — Unverified - heuristic first draft.

Last verified 96 days agoverified 96 days ago0180 days
Freshness. Last verified 96 days ago (2026-08-04); stale after 180 days.

Terms

Arbitration

Not independently confirmed this pass — standard binding arbitration + class action waiver expected.

Data sharing

A 2021 CVS Health DATABASE LEAK exposed OVER ONE BILLION RECORDS — including search queries for specific medications and vaccines — one of the largest-scale exposures found anywhere in this entire 185-company audit by raw record count, though the search-query nature of the exposed data (rather than full medical records) may limit per-person severity relative to, e.g., the 23andMe genetic-data breach elsewhere in this tracker.

Fees and billing

Not itemized this pass.

Contacts

Privacy contact. Not recorded.

Legal notice. PUBLIC COMPANY (CVS). Service route: c/o General Counsel / Corporate Secretary, Woonsocket, Rhode Island — the corporate address on the SEC Form 10-K cover page is the official address of record. Confirm the exact street address on the current 10-K at sec.gov/edgar, and check the state-of-incorporation registered agent (usually Delaware; most large filers use The Corporation Trust Company or Corporation Service Company) via the Secretary of State business-entity search. A registered agent MUST accept service, which is why it is the reliable channel when a company publishes no privacy address.

Mailing address. Not recorded.

No published channel
Paper trail: none. No published channel.

Evidence

No claims have been itemized for this row yet.

No sources are on file for this row yet.

Source vault

Link status: Candidate - not yet fetched

DocumentLast fetchPDF
Privacy policy
cvs.com/content/privacy-policy
Not fetched yetNO (HTML only)
Terms of service
cvs.com/content/terms-of-use
Not fetched yetNO (HTML only)
Website
cvshealth.com
Not fetched yet—
Primary source
No URL recorded
Verification: Unverified - heuristic first draft
Not fetched yet—

Enforcement

No enforcement actions are linked to this row.

State statute

Headquarters on file: Rhode Island. Provisions of RIDTPPA on file:

ProvisionTypeSource
Universal Opt-Out Mechanism Required at Effective Date
R.I. Gen. Laws § 6-48.1
hardsource
Privacy Notice Must Identify Third Parties by Name
R.I. Gen. Laws § 6-48.1-3(a)(2)
hardsource
Enforcement — AG; Cure Period at Enactment
R.I. Gen. Laws § 6-48.1-8
hardsource
Applicability Threshold — Low Thresholds (10k/35k)
R.I. Gen. Laws §§ 6-48.1-4 to 6-48.1-7
thresholdsource